Inhibitors of Protein Farnesyltransferase as Novel Anticancer Agents

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 3, 2002-03 ,pp. : 303-323

Bentham Science Publishers

Access to resources Recommend Favorite

The Recent Development of Farnesyltransferase Inhibitors as Anticancer and Antimalarial Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 10, 2015-08 ,pp. : 837-857

Bentham Science Publishers

Access to resources Recommend Favorite

CA 1 A 2 X-competitive inhibitors of farnesyltransferase as anti-cancer agents

By Omer C.A.   Kohl N.E.  

Trends in Pharmacological Sciences, Vol. 18, Iss. 11, 1997-11 ,pp. : 437-445

Elsevier

Access to resources Recommend Favorite

Developing FGFR4 Inhibitors As Potential Anti-Cancer Agents Via In Silico Design, Supported by In Vitro and Cell-Based Testing

By  

Current Medicinal Chemistry, Vol. 20, Iss. 10, 2013-04 ,pp. : 1203-1217

Bentham Science Publishers

Access to resources Recommend Favorite

Rational Design of Potent and Selective EGFR Tyrosine Kinase Inhibitors as Anticancer Agents

By  

Current Cancer Drug Targets, Vol. 1, Iss. 2, 2001-08 ,pp. : 129-140

Bentham Science Publishers

Access to resources Recommend Favorite